首页 > 最新文献

Medical Decision Making最新文献

英文 中文
Constrained Optimization for Decision Making in Health Care Using Python: A Tutorial. 使用Python进行医疗保健决策的约束优化:教程。
IF 3.6 3区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2023-10-01 Epub Date: 2023-07-22 DOI: 10.1177/0272989X231188027
K H Benjamin Leung, Nasrin Yousefi, Timothy C Y Chan, Ahmed M Bayoumi

Highlights: This tutorial provides a user-friendly guide to mathematically formulating constrained optimization problems and implementing them using Python.Two examples are presented to illustrate how constrained optimization is used in health applications, with accompanying Python code provided.

亮点:本教程提供了一个用户友好的指南,用于从数学上制定约束优化问题并使用Python实现这些问题。提供了两个示例来说明如何在健康应用程序中使用约束优化,并提供了附带的Python代码。
{"title":"Constrained Optimization for Decision Making in Health Care Using Python: A Tutorial.","authors":"K H Benjamin Leung, Nasrin Yousefi, Timothy C Y Chan, Ahmed M Bayoumi","doi":"10.1177/0272989X231188027","DOIUrl":"10.1177/0272989X231188027","url":null,"abstract":"<p><strong>Highlights: </strong>This tutorial provides a user-friendly guide to mathematically formulating constrained optimization problems and implementing them using Python.Two examples are presented to illustrate how constrained optimization is used in health applications, with accompanying Python code provided.</p>","PeriodicalId":49839,"journal":{"name":"Medical Decision Making","volume":" ","pages":"760-773"},"PeriodicalIF":3.6,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625722/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10227647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How Do People Process Different Representations of Statistical Information? Insights into Cognitive Effort, Representational Inconsistencies, and Individual Differences. 人们如何处理统计信息的不同表示?认知努力、表征不一致和个体差异的见解。
IF 3.6 3区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2023-10-01 Epub Date: 2023-10-16 DOI: 10.1177/0272989X231202505
Kevin E Tiede, Wolfgang Gaissmaier

Background: Graphical representation formats (e.g., icon arrays) have been shown to lead to better understanding of the benefits and risks of treatments compared to numbers. We investigate the cognitive processes underlying the effects of format on understanding: how much cognitive effort is required to process numerical and graphical representations, how people process inconsistent representations, and how numeracy and graph literacy affect information processing.

Methods: In a preregistered between-participants experiment, 665 participants answered questions about the relative frequencies of benefits and side effects of 6 medications. First, we manipulated whether the medical information was represented numerically, graphically (as icon arrays), or inconsistently (numerically for 3 medications and graphically for the other 3). Second, to examine cognitive effort, we manipulated whether there was time pressure or not. In an additional intervention condition, participants translated graphical information into numerical information before answering questions. We also assessed numeracy and graph literacy.

Results: Processing icon arrays was more strongly affected by time pressure than processing numbers, suggesting that graphical formats required more cognitive effort. Understanding was lower when information was represented inconsistently (v. consistently) but not if there was a preceding intervention. Decisions based on inconsistent representations were biased toward graphically represented options. People with higher numeracy processed quantitative information more efficiently than people with lower numeracy did. Graph literacy was not related to processing efficiency.

Limitations: Our study was conducted with a nonpatient sample, and the medical information was hypothetical.

Conclusions: Although graphical (v. numerical) formats have previously been found to lead to better understanding, they may require more cognitive effort. Therefore, the goal of risk communication may play an important role when choosing how to communicate medical information.

Highlights: This article investigates the cognitive processes underlying the effects of representation format on the understanding of statistical information and individual differences therein.Processing icon arrays required more cognitive effort than processing numbers did.When information was represented inconsistently (i.e., partly numerically and partly graphically), understanding was lower than with consistent representation, and decisions were biased toward the graphically represented options.People with higher numeracy processed quantitative information more efficiently than people with lower numeracy did.

背景:与数字相比,图形表示格式(如图标阵列)已被证明可以更好地理解治疗的益处和风险。我们研究了格式对理解影响的认知过程:处理数字和图形表示需要多少认知努力,人们如何处理不一致的表示,以及算术和图形素养如何影响信息处理。方法:在一项预先登记的参与者间实验中,665名参与者回答了关于6种药物的益处和副作用的相对频率的问题。首先,我们处理了医疗信息是以数字、图形(作为图标阵列)还是不一致(3种药物以数字表示,其他3种药物则以图形表示)。其次,为了检验认知努力,我们操纵是否存在时间压力。在另一种干预条件下,参与者在回答问题之前将图形信息转换为数字信息。我们还评估了算术和图形素养。结果:处理图标数组比处理数字更容易受到时间压力的影响,这表明图形格式需要更多的认知努力。当信息表现不一致(v.一致)时,理解力较低,但如果之前有干预,理解力则不会降低。基于不一致表示的决策偏向于图形表示的选项。计算能力较高的人比计算能力较低的人更有效地处理定量信息。图形素养与处理效率无关。局限性:我们的研究是用非患者样本进行的,医学信息是假设的。结论:尽管以前已经发现图形(v.数字)格式可以更好地理解,但它们可能需要更多的认知努力。因此,风险沟通的目标可能在选择如何沟通医疗信息时发挥重要作用。亮点:本文研究了表征形式对统计信息理解的影响及其个体差异的认知过程。处理图标数组比处理数字需要更多的认知努力。当信息表示不一致时(即,部分用数字表示,部分用图形表示),理解力低于一致表示,决策偏向于用图形表示的选项。计算能力较高的人比计算能力较低的人更有效地处理定量信息。
{"title":"How Do People Process Different Representations of Statistical Information? Insights into Cognitive Effort, Representational Inconsistencies, and Individual Differences.","authors":"Kevin E Tiede, Wolfgang Gaissmaier","doi":"10.1177/0272989X231202505","DOIUrl":"10.1177/0272989X231202505","url":null,"abstract":"<p><strong>Background: </strong>Graphical representation formats (e.g., icon arrays) have been shown to lead to better understanding of the benefits and risks of treatments compared to numbers. We investigate the cognitive processes underlying the effects of format on understanding: how much cognitive effort is required to process numerical and graphical representations, how people process inconsistent representations, and how numeracy and graph literacy affect information processing.</p><p><strong>Methods: </strong>In a preregistered between-participants experiment, 665 participants answered questions about the relative frequencies of benefits and side effects of 6 medications. First, we manipulated whether the medical information was represented numerically, graphically (as icon arrays), or inconsistently (numerically for 3 medications and graphically for the other 3). Second, to examine cognitive effort, we manipulated whether there was time pressure or not. In an additional intervention condition, participants translated graphical information into numerical information before answering questions. We also assessed numeracy and graph literacy.</p><p><strong>Results: </strong>Processing icon arrays was more strongly affected by time pressure than processing numbers, suggesting that graphical formats required more cognitive effort. Understanding was lower when information was represented inconsistently (v. consistently) but not if there was a preceding intervention. Decisions based on inconsistent representations were biased toward graphically represented options. People with higher numeracy processed quantitative information more efficiently than people with lower numeracy did. Graph literacy was not related to processing efficiency.</p><p><strong>Limitations: </strong>Our study was conducted with a nonpatient sample, and the medical information was hypothetical.</p><p><strong>Conclusions: </strong>Although graphical (v. numerical) formats have previously been found to lead to better understanding, they may require more cognitive effort. Therefore, the goal of risk communication may play an important role when choosing how to communicate medical information.</p><p><strong>Highlights: </strong>This article investigates the cognitive processes underlying the effects of representation format on the understanding of statistical information and individual differences therein.Processing icon arrays required more cognitive effort than processing numbers did.When information was represented inconsistently (i.e., partly numerically and partly graphically), understanding was lower than with consistent representation, and decisions were biased toward the graphically represented options.People with higher numeracy processed quantitative information more efficiently than people with lower numeracy did.</p>","PeriodicalId":49839,"journal":{"name":"Medical Decision Making","volume":" ","pages":"803-820"},"PeriodicalIF":3.6,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625726/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41240339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of a Naturalness Preference Scale. 自然偏好量表的编制。
IF 3.6 3区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2023-10-01 Epub Date: 2023-07-31 DOI: 10.1177/0272989X231189494
Shawna F Bayerman, Meng Li, Adnan Syed, Laura D Scherer

Objective: Naturalness preference can influence important health decisions. However, the literature lacks a reliable way to measure individual differences in naturalness preferences. We fill this gap by designing and validating a scale to measure individual differences in naturalness preference.

Methods: We conducted 3 studies among Amazon Mechanical Turk participants. In study 1 (N = 451), we created scale items through an iterative process that measured naturalness preference in hypothesized domains. We conducted exploratory factor analysis (EFA) to identify items that assess the naturalness preference construct. In study 2 (N = 448), we conducted confirmatory factor analysis (CFA) and tests of criterion, discriminant, convergent, and incremental validity. In study 3 (N = 607), we confirmed test-retest reliability of the scale and performed additional validity tests.

Results: EFA revealed 3 correlated factors consistent with naturalness preference in medicine, food, and household products. The CFA confirmed the 3-factor structure and led to the decision to drop reverse-coded items. The finalized Naturalness Preference Scale (NPS) consists of 20 items and 3 subscales: NPS-medicine, NPS-food, and NPS-household products. The NPS demonstrated good test-retest reliability, and subscales had good validity in their respective domains. The NPS-medicine subscale was predictive of the uptake of a hypothetical COVID-19 vaccine (r = -0.45) and belief in unproven natural COVID remedies and treatments (r = 0.29).

Conclusions: The NPS will allow researchers to better assess individual differences in naturalness preference and how they influence decision making and health behaviors.

Highlights: This research created and validated a scale to measure individual differences in naturalness preference in 3 domains: medicine, food, and household products.This study confirms that the strength of the naturalness preference differs in different domains.An important and timely finding is that higher scores in the naturalness preference medical subscale are associated with belief in COVID-19 misinformation and reluctance toward COVID-19 vaccination.

目的:自然偏好可以影响重要的健康决策。然而,文献缺乏一种可靠的方法来衡量自然偏好的个体差异。我们通过设计和验证一个量表来衡量自然偏好的个体差异,从而填补了这一空白。方法:我们在Amazon Mechanical Turk参与者中进行了3项研究。在研究1(N = 451),我们通过一个迭代过程创建了量表项目,该过程测量了假设领域中的自然度偏好。我们进行了探索性因素分析(EFA),以确定评估自然偏好结构的项目。在研究2中(N = 448),我们进行了验证性因素分析(CFA)和标准、判别、收敛和增量有效性测试。在研究3(N = 607),我们确认了量表的重测可靠性,并进行了额外的有效性测试。结果:在药品、食品和家居用品方面,EFA揭示了3个与自然偏好一致的相关因素。CFA确认了三因素结构,并决定放弃反向编码项目。最终确定的自然偏好量表(NPS)由20个项目和3个分量表组成:NPS药物、NPS食品和NPS家用产品。NPS表现出良好的重测可靠性,分量表在各自领域具有良好的有效性。NPS-medicine分量表预测了假设的新冠肺炎疫苗的摄入(r = -0.45)和对未经证实的天然新冠肺炎治疗方法的信念(r = 0.29)。结论:NPS将使研究人员能够更好地评估自然偏好的个体差异,以及它们如何影响决策和健康行为。亮点:这项研究创建并验证了一个量表,用于衡量三个领域的自然偏好的个体差异:医学、食品和家用产品。这项研究证实,自然性偏好的强度在不同领域有所不同。一个重要而及时的发现是,自然偏好医学分量表得分较高与相信新冠肺炎错误信息和不愿意接种新冠肺炎疫苗有关。
{"title":"Development of a Naturalness Preference Scale.","authors":"Shawna F Bayerman, Meng Li, Adnan Syed, Laura D Scherer","doi":"10.1177/0272989X231189494","DOIUrl":"10.1177/0272989X231189494","url":null,"abstract":"<p><strong>Objective: </strong>Naturalness preference can influence important health decisions. However, the literature lacks a reliable way to measure individual differences in naturalness preferences. We fill this gap by designing and validating a scale to measure individual differences in naturalness preference.</p><p><strong>Methods: </strong>We conducted 3 studies among Amazon Mechanical Turk participants. In study 1 (<i>N</i> = 451), we created scale items through an iterative process that measured naturalness preference in hypothesized domains. We conducted exploratory factor analysis (EFA) to identify items that assess the naturalness preference construct. In study 2 (<i>N</i> = 448), we conducted confirmatory factor analysis (CFA) and tests of criterion, discriminant, convergent, and incremental validity. In study 3 (<i>N</i> = 607), we confirmed test-retest reliability of the scale and performed additional validity tests.</p><p><strong>Results: </strong>EFA revealed 3 correlated factors consistent with naturalness preference in medicine, food, and household products. The CFA confirmed the 3-factor structure and led to the decision to drop reverse-coded items. The finalized Naturalness Preference Scale (NPS) consists of 20 items and 3 subscales: NPS-medicine, NPS-food, and NPS-household products. The NPS demonstrated good test-retest reliability, and subscales had good validity in their respective domains. The NPS-medicine subscale was predictive of the uptake of a hypothetical COVID-19 vaccine (<i>r</i> = -0.45) and belief in unproven natural COVID remedies and treatments (<i>r</i> = 0.29).</p><p><strong>Conclusions: </strong>The NPS will allow researchers to better assess individual differences in naturalness preference and how they influence decision making and health behaviors.</p><p><strong>Highlights: </strong>This research created and validated a scale to measure individual differences in naturalness preference in 3 domains: medicine, food, and household products.This study confirms that the strength of the naturalness preference differs in different domains.An important and timely finding is that higher scores in the naturalness preference medical subscale are associated with belief in COVID-19 misinformation and reluctance toward COVID-19 vaccination.</p>","PeriodicalId":49839,"journal":{"name":"Medical Decision Making","volume":" ","pages":"821-834"},"PeriodicalIF":3.6,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9922833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Re-revisiting the Utilities of Health States Worse than Dead: The Problem Remains. 重新审视健康国家的效用——比死亡更糟糕:问题依然存在。
IF 3.6 3区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2023-10-01 Epub Date: 2023-10-16 DOI: 10.1177/0272989X231201147
Michał Jakubczyk

Background: In valuation studies of the EQ-5D-5L instrument, the composite time tradeoff method (cTTO) is often used to elicit preferences. In cTTO, some health states are considered worse than dead (WTD) and are assigned negative utility values. However, these negative values correlate poorly with state severity, which suggests that cTTO is insufficiently sensitive. A recent threshold explanation has been offered to account for the lack of correlation: because the severity threshold beyond which a state is considered WTD differs between respondents, the correlation should be studied for individual respondents clustered by the number of WTD states. The results obtained in such a threshold approach were interpreted to disprove the insensitivity of the cTTO method.

Aim: To scrutinize the threshold explanation and test whether it indeed refutes the insensitivity of cTTO.

Methods: The study uses data from the EQ-5D-5L Polish valuation study, which includes cTTO responses from 1,510 participants, each of whom evaluated 10 EQ-5D-5L states. The correlation analysis and threshold approach are repeated to confirm the results from previous studies. The data are then modified in 2 contrasting ways. First, negative utilities are randomly reshuffled to test whether the threshold approach can capture cTTO insensitivity. Second, individual-level regressions are used to simulate negative values to ensure they correlate with severity at the individual respondent level, verifying whether the overall severity-utility correlation should be observed.

Results: First, reshuffling negative utilities does not change the results of the threshold approach. Hence, the threshold explanation fails to prove cTTO sensitivity. Second, when sensitivity was introduced on an individual level, a significant overall correlation between severity and negative utility arose.

Conclusion: cTTO is insensitive to severity for WTD states.

Highlights: For the composite time tradeoff method, the utility values of health states worse than dead correlate poorly with state severity, which suggests that cTTO has insufficient sensitivity.Recently, a so-called threshold explanation was offered for the lack of correlation.I show why the threshold explanation fails and why the composite time tradeoff is indeed insensitive for worse-than-dead states.

背景:在EQ-5D-5L仪器的评估研究中,经常使用复合时间权衡法(cTTO)来引发偏好。在cTTO中,一些健康状态被认为比死亡(WTD)更糟糕,并被赋予负效用值。然而,这些负值与状态严重程度的相关性很差,这表明cTTO不够敏感。最近提出了一种阈值解释来解释缺乏相关性的原因:由于一个州被视为WTD的严重程度阈值在受访者之间不同,因此应根据WTD州的数量对个别受访者的相关性进行研究。在这种阈值方法中获得的结果被解释为反驳了cTTO方法的不敏感性。目的:仔细审查阈值解释,并测试它是否确实反驳了cTTO的不敏感性。方法:该研究使用了EQ-5D-5L波兰评估研究的数据,该研究包括1510名参与者的cTTO反应,每个参与者评估了10个EQ-5D-5L状态。重复相关分析和阈值方法以证实先前研究的结果。然后以两种不同的方式对数据进行修改。首先,对负效用进行随机重组,以测试阈值方法是否可以捕获cTTO不敏感。其次,个人水平的回归用于模拟负值,以确保它们与个人受访者水平的严重程度相关,从而验证是否应观察到总体严重程度效用相关性。结果:首先,重组负效用不会改变阈值方法的结果。因此,阈值解释未能证明cTTO的敏感性。其次,当敏感性被引入个人层面时,严重程度和负面效用之间出现了显著的整体相关性。结论:cTTO对WTD状态的严重程度不敏感。亮点:对于复合时间权衡方法,健康状态比死亡状态差的效用值与状态严重程度的相关性较差,这表明cTTO的敏感性不足。最近,对于缺乏相关性提出了一种所谓的阈值解释。我展示了为什么阈值解释失败,以及为什么复合时间权衡确实对比死状态更糟糕的状态不敏感。
{"title":"Re-revisiting the Utilities of Health States Worse than Dead: The Problem Remains.","authors":"Michał Jakubczyk","doi":"10.1177/0272989X231201147","DOIUrl":"10.1177/0272989X231201147","url":null,"abstract":"<p><strong>Background: </strong>In valuation studies of the EQ-5D-5L instrument, the composite time tradeoff method (cTTO) is often used to elicit preferences. In cTTO, some health states are considered worse than dead (WTD) and are assigned negative utility values. However, these negative values correlate poorly with state severity, which suggests that cTTO is insufficiently sensitive. A recent threshold explanation has been offered to account for the lack of correlation: because the severity threshold beyond which a state is considered WTD differs between respondents, the correlation should be studied for individual respondents clustered by the number of WTD states. The results obtained in such a threshold approach were interpreted to disprove the insensitivity of the cTTO method.</p><p><strong>Aim: </strong>To scrutinize the threshold explanation and test whether it indeed refutes the insensitivity of cTTO.</p><p><strong>Methods: </strong>The study uses data from the EQ-5D-5L Polish valuation study, which includes cTTO responses from 1,510 participants, each of whom evaluated 10 EQ-5D-5L states. The correlation analysis and threshold approach are repeated to confirm the results from previous studies. The data are then modified in 2 contrasting ways. First, negative utilities are randomly reshuffled to test whether the threshold approach can capture cTTO insensitivity. Second, individual-level regressions are used to simulate negative values to ensure they correlate with severity at the individual respondent level, verifying whether the overall severity-utility correlation should be observed.</p><p><strong>Results: </strong>First, reshuffling negative utilities does not change the results of the threshold approach. Hence, the threshold explanation fails to prove cTTO sensitivity. Second, when sensitivity was introduced on an individual level, a significant overall correlation between severity and negative utility arose.</p><p><strong>Conclusion: </strong>cTTO is insensitive to severity for WTD states.</p><p><strong>Highlights: </strong>For the composite time tradeoff method, the utility values of health states worse than dead correlate poorly with state severity, which suggests that cTTO has insufficient sensitivity.Recently, a so-called threshold explanation was offered for the lack of correlation.I show why the threshold explanation fails and why the composite time tradeoff is indeed insensitive for worse-than-dead states.</p>","PeriodicalId":49839,"journal":{"name":"Medical Decision Making","volume":" ","pages":"875-885"},"PeriodicalIF":3.6,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41240340","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cost-Effectiveness Analysis for Therapy Sequence in Advanced Cancer: A Microsimulation Approach with Application to Metastatic Prostate Cancer. 晚期癌症治疗序列的共效分析:一种微刺激方法及其在转移性癌症前列腺癌中的应用。
IF 3.6 3区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2023-10-01 Epub Date: 2023-10-09 DOI: 10.1177/0272989X231201621
Elizabeth A Handorf, J Robert Beck, Andres Correa, Chethan Ramamurthy, Daniel M Geynisman

Purpose: Patients with advanced cancer may undergo multiple lines of treatment, switching therapies as their disease progresses. We developed a general microsimulation framework to study therapy sequence and applied it to metastatic prostate cancer.

Methods: We constructed a discrete-time state transition model to study 2 lines of therapy. Using digitized published survival curves (progression-free survival, time to progression, and overall survival [OS]), we inferred event types (progression or death) and estimated transition probabilities using cumulative incidence functions with competing risks. We incorporated within-patient dependence over time; first-line therapy response informed subsequent event probabilities. Parameters governing within-patient dependence calibrated the model-based results to a target clinical trial. We applied these methods to 2 therapy sequences for metastatic prostate cancer, wherein both docetaxel (DCT) and abiraterone acetate (AA) are appropriate for either first- or second-line treatment. We assessed costs and quality-adjusted life-years (5-y QALYs) for 2 treatment strategies: DCT → AA versus AA → DCT.

Results: Models assuming within-patient independence overestimated OS time, which corrected with the calibration approach. With generic pricing, AA → DCT dominated DCT → AA, (higher 5-y QALYs and lower costs), consistent for all values of calibration parameters (including no correction). Model calibration increased the difference in 5-y QALYs between treatment strategies (0.07 uncorrected v. 0.15 with base-case correction). Applying the correction decreased the estimated difference in cost (-$5,360 uncorrected v. -$3,066 corrected). Results were strongly affected by the cost of AA. Under a lifetime horizon, AA → DCT was no longer dominant but still cost-effective (incremental cost-effectiveness ratio: $19,463).

Conclusions: We demonstrate a microsimulation approach to study the cost-effectiveness of therapy sequences for advanced prostate cancer, taking care to account for within-patient dependence.

Highlights: We developed a discrete-time state transition model for studying therapy sequence in advanced cancers.Results are sensitive to dependence within patients.A calibration approach can introduce dependence across lines of therapy and closely match simulation outcomes to target trial outcomes.

目的:晚期癌症患者可能会接受多种治疗,随着病情的发展而改变治疗方式。我们开发了一个通用的微刺激框架来研究治疗序列,并将其应用于转移性前列腺癌症。方法:我们构建了一个离散时间状态转换模型来研究两种治疗方法。使用数字化公布的生存曲线(无进展生存率、进展时间和总生存率[OS]),我们推断了事件类型(进展或死亡),并使用具有竞争风险的累积发病率函数估计了转移概率。随着时间的推移,我们纳入了患者的依赖性;一线治疗反应告知后续事件概率。控制患者内部依赖性的参数将基于模型的结果校准为目标临床试验。我们将这些方法应用于转移性前列腺癌症的2个治疗序列,其中多烯紫杉醇(DCT)和乙酸阿比特龙(AA)均适用于一线或二线治疗。我们评估了两种治疗策略的成本和质量调整寿命(5年QALYs):DCT→ AA与AA→ 结果:假设患者内独立性的模型高估了OS时间,并用校准方法进行了校正。采用通用定价,AA→ DCT为主的DCT→ AA,(更高的5-y QALYs和更低的成本),与校准参数的所有值一致(包括无校正)。模型校准增加了治疗策略之间5-y QALYs的差异(0.07未校正vs.0.15有基本情况校正)。应用修正减少了估计的成本差异(未修正的-5360美元与修正的-3066美元)。结果受到AA成本的强烈影响。在寿命范围内,AA→ DCT不再占主导地位,但仍然具有成本效益(增量成本效益比:$19463)。结论:我们证明了一种微刺激方法来研究晚期前列腺癌症治疗序列的成本效益,同时考虑患者内的依赖性。亮点:我们开发了一个离散时间状态转换模型,用于研究晚期癌症的治疗序列。结果对患者的依赖性很敏感。校准方法可以引入跨治疗线的依赖性,并将模拟结果与目标试验结果紧密匹配。
{"title":"Cost-Effectiveness Analysis for Therapy Sequence in Advanced Cancer: A Microsimulation Approach with Application to Metastatic Prostate Cancer.","authors":"Elizabeth A Handorf, J Robert Beck, Andres Correa, Chethan Ramamurthy, Daniel M Geynisman","doi":"10.1177/0272989X231201621","DOIUrl":"10.1177/0272989X231201621","url":null,"abstract":"<p><strong>Purpose: </strong>Patients with advanced cancer may undergo multiple lines of treatment, switching therapies as their disease progresses. We developed a general microsimulation framework to study therapy sequence and applied it to metastatic prostate cancer.</p><p><strong>Methods: </strong>We constructed a discrete-time state transition model to study 2 lines of therapy. Using digitized published survival curves (progression-free survival, time to progression, and overall survival [OS]), we inferred event types (progression or death) and estimated transition probabilities using cumulative incidence functions with competing risks. We incorporated within-patient dependence over time; first-line therapy response informed subsequent event probabilities. Parameters governing within-patient dependence calibrated the model-based results to a target clinical trial. We applied these methods to 2 therapy sequences for metastatic prostate cancer, wherein both docetaxel (DCT) and abiraterone acetate (AA) are appropriate for either first- or second-line treatment. We assessed costs and quality-adjusted life-years (5-y QALYs) for 2 treatment strategies: DCT → AA versus AA → DCT.</p><p><strong>Results: </strong>Models assuming within-patient independence overestimated OS time, which corrected with the calibration approach. With generic pricing, AA → DCT dominated DCT → AA, (higher 5-y QALYs and lower costs), consistent for all values of calibration parameters (including no correction). Model calibration increased the difference in 5-y QALYs between treatment strategies (0.07 uncorrected v. 0.15 with base-case correction). Applying the correction decreased the estimated difference in cost (-$5,360 uncorrected v. -$3,066 corrected). Results were strongly affected by the cost of AA. Under a lifetime horizon, AA → DCT was no longer dominant but still cost-effective (incremental cost-effectiveness ratio: $19,463).</p><p><strong>Conclusions: </strong>We demonstrate a microsimulation approach to study the cost-effectiveness of therapy sequences for advanced prostate cancer, taking care to account for within-patient dependence.</p><p><strong>Highlights: </strong>We developed a discrete-time state transition model for studying therapy sequence in advanced cancers.Results are sensitive to dependence within patients.A calibration approach can introduce dependence across lines of therapy and closely match simulation outcomes to target trial outcomes.</p>","PeriodicalId":49839,"journal":{"name":"Medical Decision Making","volume":" ","pages":"949-960"},"PeriodicalIF":3.6,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10840915/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41162391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Verity of a Unifying Diagnosis. 统一诊断的真实性。
IF 3.1 3区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2023-10-01 Epub Date: 2023-09-14 DOI: 10.1177/0272989X231192521
Brian W Locke, Scott K Aberegg
{"title":"The Verity of a Unifying Diagnosis.","authors":"Brian W Locke, Scott K Aberegg","doi":"10.1177/0272989X231192521","DOIUrl":"10.1177/0272989X231192521","url":null,"abstract":"","PeriodicalId":49839,"journal":{"name":"Medical Decision Making","volume":" ","pages":"755-757"},"PeriodicalIF":3.1,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10841113/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10580865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health Economic Analysis of Antiviral Drugs in the Global Polio Eradication Endgame. 全球根除脊髓灰质炎最后阶段抗病毒药物的健康经济分析。
IF 3.6 3区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2023-10-01 Epub Date: 2023-08-14 DOI: 10.1177/0272989X231191127
Kamran Badizadegan, Dominika A Kalkowska, Kimberly M Thompson

Background: Polio antiviral drugs (PAVDs) may provide a critical tool in the eradication endgame by stopping poliovirus infections in immunodeficient individuals who may not clear the virus without therapeutic intervention. Although prolonged/chronic poliovirus excreters are rare, they represent a source of poliovirus reintroduction into the general population. Prior studies that assumed the successful cessation of all oral poliovirus vaccine (OPV) use estimated the potential upper bound of the incremental net benefits (INBs) of resource investments in research and development of PAVDs. However, delays in polio eradication, OPV cessation, and the development of PAVDs necessitate an updated economic analysis to reevaluate the costs and benefits of further investments in PAVDs.

Methods: Using a global integrated model of polio transmission, immunity, vaccine dynamics, risks, and economics, we explore the risks of reintroduction of polio transmission due to immunodeficiency-related vaccine-derived poliovirus (iVDPV) excreters and reevaluate the upper bound of the INBs of PAVDs.

Results: Under the current conditions, for which the use of OPV will likely continue for the foreseeable future, even with successful eradication of type 1 wild poliovirus by the end of 2023 and continued use of Sabin OPV for outbreak response, we estimate an upper bound INB of 60 million US$2019. With >100 million US$2019 already invested in PAVD development and with the introduction of novel OPVs that are less likely to revert to neurovirulence, our analysis suggests the expected INBs of PAVDs would not offset their costs.

Conclusions: While PAVDs could play an important role in the polio endgame, their expected economic benefits drop with ongoing OPV use and poliovirus transmissions. However, stakeholders may pursue the development of PAVDs as a desired product regardless of their economic benefits.HighlightsWhile polio antiviral drugs could play an important role in the polio endgame, their expected economic benefits continue to drop with delays in polio eradication and the continued use of oral poliovirus vaccines.The incremental net benefits of investments in polio antiviral drug development and screening for immunodeficiency-related circulating polioviruses are small.Limited global resources are better spent on increasing global population immunity to polioviruses to stop and prevent poliovirus transmission.

背景:脊髓灰质炎抗病毒药物(PAVDs)可以通过阻止免疫缺陷个体的脊髓灰质炎病毒感染,为根除脊髓灰质炎提供一个关键工具,这些免疫缺陷个体在没有治疗干预的情况下可能无法清除病毒。尽管长期/慢性脊髓灰质炎病毒排泄物很少,但它们是脊髓灰质炎病毒重新引入普通人群的来源。先前的研究假设成功停止所有口服脊髓灰质炎病毒疫苗(OPV)的使用,估计了PAVD研发中资源投资的增量净效益(INBs)的潜在上限。然而,根除脊髓灰质炎、停止口服脊髓灰质炎病毒和开发PAVD的延迟需要进行最新的经济分析,以重新评估对PAVD的进一步投资的成本和效益。方法:使用脊髓灰质炎传播、免疫、疫苗动力学、风险和经济的全球综合模型,我们探讨了由免疫缺陷相关疫苗衍生脊髓灰质炎病毒(iVDPV)排泄物引起的脊髓灰质炎再次传播的风险,并重新评估了PAVD的INBs的上限。结果:在目前的条件下,OPV的使用可能在可预见的未来继续,即使在2023年底成功根除了1型野生脊髓灰质炎病毒,并继续使用Sabin OPV应对疫情,我们估计2019年的INB上限为6000万美元。由于2019年已投资超过1亿美元用于PAVD的开发,并且引入了不太可能恢复神经毒力的新型OPV,我们的分析表明,PAVD的预期INB不会抵消其成本。结论:虽然PAVD可能在脊髓灰质炎的结局中发挥重要作用,但随着口服脊髓灰质炎病毒的持续使用和脊髓灰质炎病毒的传播,其预期经济效益下降。然而,利益相关者可能会将PAVD开发为所需产品,而不管其经济效益如何。重点尽管脊髓灰质炎抗病毒药物可能在脊髓灰质炎的结局中发挥重要作用,但随着根除脊髓灰质炎的延迟和口服脊髓灰质炎病毒疫苗的继续使用,其预期经济效益继续下降。脊髓灰质炎抗病毒药物开发和免疫缺陷相关脊髓灰质炎循环病毒筛查投资的增量净收益很小。有限的全球资源最好用于提高全球人口对脊髓灰质炎病毒的免疫力,以阻止和预防脊髓灰质炎病毒的传播。
{"title":"Health Economic Analysis of Antiviral Drugs in the Global Polio Eradication Endgame.","authors":"Kamran Badizadegan, Dominika A Kalkowska, Kimberly M Thompson","doi":"10.1177/0272989X231191127","DOIUrl":"10.1177/0272989X231191127","url":null,"abstract":"<p><strong>Background: </strong>Polio antiviral drugs (PAVDs) may provide a critical tool in the eradication endgame by stopping poliovirus infections in immunodeficient individuals who may not clear the virus without therapeutic intervention. Although prolonged/chronic poliovirus excreters are rare, they represent a source of poliovirus reintroduction into the general population. Prior studies that assumed the successful cessation of all oral poliovirus vaccine (OPV) use estimated the potential upper bound of the incremental net benefits (INBs) of resource investments in research and development of PAVDs. However, delays in polio eradication, OPV cessation, and the development of PAVDs necessitate an updated economic analysis to reevaluate the costs and benefits of further investments in PAVDs.</p><p><strong>Methods: </strong>Using a global integrated model of polio transmission, immunity, vaccine dynamics, risks, and economics, we explore the risks of reintroduction of polio transmission due to immunodeficiency-related vaccine-derived poliovirus (iVDPV) excreters and reevaluate the upper bound of the INBs of PAVDs.</p><p><strong>Results: </strong>Under the current conditions, for which the use of OPV will likely continue for the foreseeable future, even with successful eradication of type 1 wild poliovirus by the end of 2023 and continued use of Sabin OPV for outbreak response, we estimate an upper bound INB of 60 million US$2019. With >100 million US$2019 already invested in PAVD development and with the introduction of novel OPVs that are less likely to revert to neurovirulence, our analysis suggests the expected INBs of PAVDs would not offset their costs.</p><p><strong>Conclusions: </strong>While PAVDs could play an important role in the polio endgame, their expected economic benefits drop with ongoing OPV use and poliovirus transmissions. However, stakeholders may pursue the development of PAVDs as a desired product regardless of their economic benefits.HighlightsWhile polio antiviral drugs could play an important role in the polio endgame, their expected economic benefits continue to drop with delays in polio eradication and the continued use of oral poliovirus vaccines.The incremental net benefits of investments in polio antiviral drug development and screening for immunodeficiency-related circulating polioviruses are small.Limited global resources are better spent on increasing global population immunity to polioviruses to stop and prevent poliovirus transmission.</p>","PeriodicalId":49839,"journal":{"name":"Medical Decision Making","volume":" ","pages":"850-862"},"PeriodicalIF":3.6,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680042/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9981541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How Should Doctors Frame the Risk of a Vaccine's Adverse Side Effects? It Depends on How Trustworthy They Are. 医生应该如何界定疫苗不良副作用的风险?这取决于他们的可信度。
IF 3.6 3区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2023-10-01 Epub Date: 2023-09-26 DOI: 10.1177/0272989X231197646
Marie Juanchich, Miroslav Sirota, Dawn Liu Holford

Background: How health workers frame their communication about vaccines' probability of adverse side effects could play an important role in people's intentions to be vaccinated (e.g., positive frame: side effects are unlikely v. negative frame: there is a chance of side effects). Based on the pragmatic account of framing as implicit advice, we expected that participants would report greater vaccination intentions when a trustworthy physician framed the risks positively (v. negatively), but we expected this effect would be reduced or reversed when the physician was untrustworthy.

Design: In 4 online experiments (n = 191, snowball sampling and n = 453, 451, and 464 UK residents via Prolific; Mage≈ 34 y, 70% women, 84% White British), we manipulated the trustworthiness of a physician and how they framed the risk of adverse side effects in a scenario (i.e., a chance v. unlikely adverse side effects). Participants reported their vaccination intention, their level of distrust in health care systems, and COVID-19 conspiracy beliefs.

Results: Physicians who were trustworthy (v. untrustworthy) consistently led to an increase in vaccination intention, but the way they described adverse side effects mattered too. A positive framing of the risks given by a trustworthy physician consistently led to increased vaccination intention relative to a negative framing, but framing had no effect or the opposite effect when given by an untrustworthy physician. The exception to this trend occurred in unvaccinated individuals in experiment 3, following serious concerns about one of the COVID vaccines. In that study, unvaccinated participants responded more favorably to the negative framing of the trustworthy physician.

Conclusions: Trusted sources should use positive framing to foster vaccination acceptance. However, in a situation of heightened fears, a negative framing-attracting more attention to the risks-might be more effective.

Highlights: How health workers frame their communication about a vaccine's probability of adverse side effects plays an important role in people's intentions to be vaccinated.In 4 experiments, we manipulated the trustworthiness of a physician and how the physician framed the risk of adverse side effects of a COVID vaccine.Positive framing given by a trustworthy physician promoted vaccination intention but had null effect or did backfire when given by an untrustworthy physician.The effect occurred over and above participants' attitude toward the health care system, risk perceptions, and beliefs in COVID misinformation.

背景:卫生工作者如何就疫苗的不良副作用概率进行沟通,可能对人们接种疫苗的意图起着重要作用(例如,积极框架:副作用不太可能;消极框架:有副作用的可能性)。基于将框架视为隐含建议的务实解释,我们预计,当一位值得信赖的医生对风险进行积极的框架(v.消极的框架)时,参与者会报告更大的疫苗接种意向,但当医生不值得信赖时,我们预计这种影响会减少或逆转。设计:在4个在线实验中(n = 191,雪球采样和n = 453451和464名英国居民通过Prolific;Mage≈34 y,70%为女性,84%为英国白人),我们操纵了医生的可信度,以及他们如何在一种情况下确定不良副作用的风险(即偶然与不太可能的不良副作用)。参与者报告了他们的疫苗接种意图、对医疗保健系统的不信任程度以及新冠肺炎阴谋信念。结果:值得信赖(v.不值得信赖)的医生一直导致疫苗接种意愿的增加,但他们描述不良副作用的方式也很重要。与消极框架相比,值得信赖的医生对风险的积极框架始终会导致疫苗接种意愿的增加,但当由不值得信任的医生提供时,框架没有效果或相反的效果。这一趋势的例外发生在实验3中未接种疫苗的个体身上,此前人们对其中一种新冠疫苗表示严重担忧。在那项研究中,未接种疫苗的参与者对值得信赖的医生的负面评价反应更积极。结论:可靠的来源应该使用积极的框架来促进疫苗接种的接受。然而,在恐惧加剧的情况下,吸引更多人关注风险的负面框架可能更有效。亮点:卫生工作者如何就疫苗的不良副作用概率进行沟通,对人们接种疫苗的意愿起着重要作用。在4个实验中,我们操纵了医生的可信度,以及医生如何确定新冠肺炎疫苗的不良副作用风险。值得信赖的医生给出的积极框架促进了疫苗接种的意图,但在不值得信赖的医师给出时无效或适得其反。这种影响发生在参与者对医疗保健系统的态度、风险认知和对新冠肺炎错误信息的信念之上。
{"title":"How Should Doctors Frame the Risk of a Vaccine's Adverse Side Effects? It Depends on How Trustworthy They Are.","authors":"Marie Juanchich, Miroslav Sirota, Dawn Liu Holford","doi":"10.1177/0272989X231197646","DOIUrl":"10.1177/0272989X231197646","url":null,"abstract":"<p><strong>Background: </strong>How health workers frame their communication about vaccines' probability of adverse side effects could play an important role in people's intentions to be vaccinated (e.g., positive frame: side effects are <i>unlikely</i> v. negative frame: there is <i>a chance</i> of side effects). Based on the pragmatic account of framing as implicit advice, we expected that participants would report greater vaccination intentions when a trustworthy physician framed the risks positively (v. negatively), but we expected this effect would be reduced or reversed when the physician was untrustworthy.</p><p><strong>Design: </strong>In 4 online experiments (<i>n</i> = 191, snowball sampling and <i>n</i> = 453, 451, and 464 UK residents via Prolific; M<sub>age</sub>≈ 34 y, 70% women, 84% White British), we manipulated the trustworthiness of a physician and how they framed the risk of adverse side effects in a scenario (i.e., a chance v. unlikely adverse side effects). Participants reported their vaccination intention, their level of distrust in health care systems, and COVID-19 conspiracy beliefs.</p><p><strong>Results: </strong>Physicians who were trustworthy (v. untrustworthy) consistently led to an increase in vaccination intention, but the way they described adverse side effects mattered too. A positive framing of the risks given by a trustworthy physician consistently led to increased vaccination intention relative to a negative framing, but framing had no effect or the opposite effect when given by an untrustworthy physician. The exception to this trend occurred in unvaccinated individuals in experiment 3, following serious concerns about one of the COVID vaccines. In that study, unvaccinated participants responded more favorably to the negative framing of the trustworthy physician.</p><p><strong>Conclusions: </strong>Trusted sources should use positive framing to foster vaccination acceptance. However, in a situation of heightened fears, a negative framing-attracting more attention to the risks-might be more effective.</p><p><strong>Highlights: </strong>How health workers frame their communication about a vaccine's probability of adverse side effects plays an important role in people's intentions to be vaccinated.In 4 experiments, we manipulated the trustworthiness of a physician and how the physician framed the risk of adverse side effects of a COVID vaccine.Positive framing given by a trustworthy physician promoted vaccination intention but had null effect or did backfire when given by an untrustworthy physician.The effect occurred over and above participants' attitude toward the health care system, risk perceptions, and beliefs in COVID misinformation.</p>","PeriodicalId":49839,"journal":{"name":"Medical Decision Making","volume":" ","pages":"835-849"},"PeriodicalIF":3.6,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625727/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41122675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Valuing the Dental Caries Utility Index in Australia. 评估澳大利亚的龋齿实用指数。
IF 3.6 3区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2023-10-01 Epub Date: 2023-09-19 DOI: 10.1177/0272989X231197149
Ruvini M Hettiarachchi, Sanjeewa Kularatna, Joshua Byrnes, Brendan Mulhern, Gang Chen, Paul A Scuffham

Introduction: The Dental Caries Utility Index (DCUI) is a new oral health-specific health state classification system for adolescents, consisting of 5 domains: pain/discomfort, difficulty eating food/drinking, worried, ability to participate in activities, and appearance. Each domain has 4 response levels. This study aims to generate an Australian-specific utility algorithm for the DCUI.

Methods: An online survey was conducted using a representative sample of the adult Australian general population. The discrete choice experiment (DCE) was used to elicit the preferences on 5 domains. Then, the latent utilities were anchored onto the full health-dead scale using the visual analogue scale (VAS). DCE data were modeled using conditional logit, and 2 anchoring procedures were considered: anchor based on the worst health state and a mapping approach. The optimal anchoring procedure was selected based on the model parsimony and the mean absolute error (MAE).

Results: A total of 995 adults from the Australian general population completed the survey. The conditional logit estimates on 5 dimensions and levels were monotonic and statistically significant, except for the second level of the "worried" and "appearance" domains. The mapping approach was selected based on a smaller MAE between the 2 anchoring procedures. The Australian-specific tariff of DCUI ranges from 0.1681 to 1.

Conclusion: This study developed a utility algorithm for the DCUI. This value set will facilitate utility value calculations from the participants' responses for DCUI in economic evaluations of dental caries interventions targeted for adolescents.

Highlights: Preference-based quality-of-life measures (PBMs), which consist of a health state classification system and a set of utility values (a scoring algorithm), are used to generate utility weights for economic evaluations.This study is the first to develop an Australian utility value set for the Dental Caries Utility Index (DCUI), a new oral health-specific classification system for adolescents.The availability of a utility value set will enable using DCUI in economic evaluations of oral health interventions targeted for adolescents and may ultimately lead to more effective and efficient planning of oral health care services.

简介:龋齿实用指数(DCUI)是一个新的针对青少年口腔健康的健康状态分类系统,由5个领域组成:疼痛/不适、进食/饮水困难、担忧、参与活动的能力和外表。每个域有4个响应级别。本研究旨在为DCUI生成一个澳大利亚特有的效用算法。方法:使用澳大利亚成年普通人群的代表性样本进行在线调查。离散选择实验(DCE)用于引出对5个领域的偏好。然后,使用视觉模拟量表(VAS)将潜在效用锚定在全健康死亡量表上。DCE数据使用条件logit建模,并考虑了2个锚定过程:基于最坏健康状态的锚定和映射方法。基于模型简约性和平均绝对误差(MAE)选择了最佳锚固程序。结果:共有995名来自澳大利亚普通人群的成年人完成了调查。除“担忧”和“外表”领域的第二层次外,5个维度和层次上的条件logit估计是单调的,具有统计学意义。标测方法是基于两个锚定程序之间较小的MAE选择的。DCUI的澳大利亚比关税在0.1681到1之间。结论:本研究开发了一种DCUI的实用算法。在针对青少年的龋齿干预措施的经济评估中,该值集将有助于从参与者对DCUI的反应中计算效用值。亮点:基于偏好的生活质量指标(PBM)由健康状态分类系统和一组效用值(评分算法)组成,用于生成经济评估的效用权重。这项研究首次为龋齿效用指数(DCUI)开发了一个澳大利亚效用值集,这是一个新的针对青少年口腔健康的分类系统。实用价值集的可用性将使DCUI能够用于针对青少年的口腔健康干预措施的经济评估,并可能最终导致口腔健康护理服务的更有效规划。
{"title":"Valuing the Dental Caries Utility Index in Australia.","authors":"Ruvini M Hettiarachchi, Sanjeewa Kularatna, Joshua Byrnes, Brendan Mulhern, Gang Chen, Paul A Scuffham","doi":"10.1177/0272989X231197149","DOIUrl":"10.1177/0272989X231197149","url":null,"abstract":"<p><strong>Introduction: </strong>The Dental Caries Utility Index (DCUI) is a new oral health-specific health state classification system for adolescents, consisting of 5 domains: pain/discomfort, difficulty eating food/drinking, worried, ability to participate in activities, and appearance. Each domain has 4 response levels. This study aims to generate an Australian-specific utility algorithm for the DCUI.</p><p><strong>Methods: </strong>An online survey was conducted using a representative sample of the adult Australian general population. The discrete choice experiment (DCE) was used to elicit the preferences on 5 domains. Then, the latent utilities were anchored onto the full health-dead scale using the visual analogue scale (VAS). DCE data were modeled using conditional logit, and 2 anchoring procedures were considered: anchor based on the worst health state and a mapping approach. The optimal anchoring procedure was selected based on the model parsimony and the mean absolute error (MAE).</p><p><strong>Results: </strong>A total of 995 adults from the Australian general population completed the survey. The conditional logit estimates on 5 dimensions and levels were monotonic and statistically significant, except for the second level of the \"worried\" and \"appearance\" domains. The mapping approach was selected based on a smaller MAE between the 2 anchoring procedures. The Australian-specific tariff of DCUI ranges from 0.1681 to 1.</p><p><strong>Conclusion: </strong>This study developed a utility algorithm for the DCUI. This value set will facilitate utility value calculations from the participants' responses for DCUI in economic evaluations of dental caries interventions targeted for adolescents.</p><p><strong>Highlights: </strong>Preference-based quality-of-life measures (PBMs), which consist of a health state classification system and a set of utility values (a scoring algorithm), are used to generate utility weights for economic evaluations.This study is the first to develop an Australian utility value set for the Dental Caries Utility Index (DCUI), a new oral health-specific classification system for adolescents.The availability of a utility value set will enable using DCUI in economic evaluations of oral health interventions targeted for adolescents and may ultimately lead to more effective and efficient planning of oral health care services.</p>","PeriodicalId":49839,"journal":{"name":"Medical Decision Making","volume":" ","pages":"901-913"},"PeriodicalIF":3.6,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625724/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41157652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Prospective Cohort Study of Medical Decision-Making Roles and Their Associations with Patient Characteristics and Patient-Reported Outcomes among Patients with Heart Failure. 心力衰竭患者医疗决策作用及其与患者特征和患者报告结果的相关性的前瞻性队列研究。
IF 3.6 3区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Pub Date : 2023-10-01 Epub Date: 2023-09-28 DOI: 10.1177/0272989X231201609
Semra Ozdemir, Jia Jia Lee, Khung Keong Yeo, Kheng Leng David Sim, Eric Andrew Finkelstein, Chetna Malhotra
<p><strong>Objective: </strong>Among patients with heart failure (HF), we examined 1) the evolution of patient involvement in decision making over 2 y, 2) the association of patient characteristics with decision-making roles, and 3) the association of decision-making roles with distress, spiritual well-being, and quality of physician communication.</p><p><strong>Methods: </strong>We administered the survey every 4 mo over 24 mo to patients with New York Heart Association class 3/4 symptoms recruited from inpatient clinics. The decision-making roles were categorized as no patient involvement, physician/family-led, joint (with family and/or physicians), patient-led, or patient-alone decision making. The associations between patient characteristics and decision-making roles were assessed using a mixed-effects ordered logistic regression, whereas those between patient outcomes and decision-making roles were investigated using mixed-effects linear regressions.</p><p><strong>Results: </strong>Of the 557 patients invited, 251 participated in the study. The most common roles in decision making at baseline assessment were "no involvement" (27.53%) and "patient-alone decision making" (25.10%). The proportions of different decision-making roles did not change over 2 y (<i>P</i> = 0.37). Older age (odds ratio [OR] = 0.97; <i>P</i> = 0.003) and being married (OR = 0.63; <i>P</i> = 0.035) were associated with lower involvement in decision making. Chinese ethnicity (OR = 1.91; <i>P</i> = 0.003), higher education (OR = 1.87; <i>P</i> = 0.003), awareness of terminal condition (OR = 2.00; <i>P</i> < 0.001), and adequate self-care confidence (OR = 1.74; <i>P</i> < 0.001) were associated with greater involvement. Compared with no patient involvement, joint (β = -0.58; <i>P</i> = 0.026) and patient-led (β = -0.59; <i>P</i> = 0.014) decision making were associated with lower distress, while family/physician-led (β = 4.37; <i>P</i> = 0.001), joint (β = 3.86; <i>P</i> < 0.001), patient-led (β = 3.46; <i>P</i> < 0.001), and patient-alone (β = 3.99; <i>P</i> < 0.001) decision making were associated with better spiritual well-being.</p><p><strong>Conclusion: </strong>A substantial proportion of patients was not involved in decision making. Patients should be encouraged to participate in decision making since it is associated with lower distress and better spiritual well-being.</p><p><strong>Highlights: </strong>The level of involvement in medical decision making did not change over time among patients with heart failure. A substantial proportion of patients were not involved in decision making throughout the 24-mo study period.Patients' involvement in decision making varied by age, ethnicity, education level, marital status, awareness of the terminal condition, and confidence in self-care.Compared with no patient involvement in decision making, joint and patient-led decision making were associated with lower distress, and any level of patient involvement in decision making
目的:在心力衰竭(HF)患者中,我们研究了1)2年来患者参与决策的演变,2)患者特征与决策角色的关系,以及3)决策角色与痛苦、精神健康和医生沟通质量的关系。方法:我们每4年进行一次调查 莫超过24 mo至从住院诊所招募的具有纽约心脏协会3/4级症状的患者。决策角色分为无患者参与、医生/家庭主导、联合(与家人和/或医生)、患者主导或患者单独决策。使用混合效应有序逻辑回归评估患者特征与决策角色之间的关联,而使用混合效应线性回归调查患者结果与决策角色间的关联。结果:在557名受邀患者中,251人参与了这项研究。在基线评估中,决策中最常见的角色是“无参与”(27.53%)和“患者单独决策”(25.10%)。不同决策角色的比例在2年内没有变化(P = 0.37)。年龄较大(比值比[OR] = 0.97;P = 0.003)并结婚(或 = 0.63;P = 0.035)与决策参与度较低有关。华裔(或 = 1.91;P = 0.003),高等教育(OR = 1.87;P = 0.003),意识到终端条件(OR = 2.00;P P P = 0.026)和患者主导(β = -0.59;P = 0.014)决策与较低的痛苦相关,而家庭/医生主导的(β = 4.37;P = 0.001),关节(β = 3.86;P P P 结论:相当一部分患者没有参与决策。应该鼓励患者参与决策,因为这与较低的痛苦和更好的精神健康有关。亮点:心力衰竭患者参与医疗决策的程度没有随着时间的推移而改变。在整个24个月的研究期间,很大一部分患者没有参与决策。患者参与决策的程度因年龄、种族、教育水平、婚姻状况、对晚期疾病的认识和自我护理的信心而异。与没有患者参与决策相比,联合和患者主导的决策与较低的痛苦相关,任何程度的患者参与决策都与更好的精神健康相关。
{"title":"A Prospective Cohort Study of Medical Decision-Making Roles and Their Associations with Patient Characteristics and Patient-Reported Outcomes among Patients with Heart Failure.","authors":"Semra Ozdemir, Jia Jia Lee, Khung Keong Yeo, Kheng Leng David Sim, Eric Andrew Finkelstein, Chetna Malhotra","doi":"10.1177/0272989X231201609","DOIUrl":"10.1177/0272989X231201609","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;Among patients with heart failure (HF), we examined 1) the evolution of patient involvement in decision making over 2 y, 2) the association of patient characteristics with decision-making roles, and 3) the association of decision-making roles with distress, spiritual well-being, and quality of physician communication.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;We administered the survey every 4 mo over 24 mo to patients with New York Heart Association class 3/4 symptoms recruited from inpatient clinics. The decision-making roles were categorized as no patient involvement, physician/family-led, joint (with family and/or physicians), patient-led, or patient-alone decision making. The associations between patient characteristics and decision-making roles were assessed using a mixed-effects ordered logistic regression, whereas those between patient outcomes and decision-making roles were investigated using mixed-effects linear regressions.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Of the 557 patients invited, 251 participated in the study. The most common roles in decision making at baseline assessment were \"no involvement\" (27.53%) and \"patient-alone decision making\" (25.10%). The proportions of different decision-making roles did not change over 2 y (&lt;i&gt;P&lt;/i&gt; = 0.37). Older age (odds ratio [OR] = 0.97; &lt;i&gt;P&lt;/i&gt; = 0.003) and being married (OR = 0.63; &lt;i&gt;P&lt;/i&gt; = 0.035) were associated with lower involvement in decision making. Chinese ethnicity (OR = 1.91; &lt;i&gt;P&lt;/i&gt; = 0.003), higher education (OR = 1.87; &lt;i&gt;P&lt;/i&gt; = 0.003), awareness of terminal condition (OR = 2.00; &lt;i&gt;P&lt;/i&gt; &lt; 0.001), and adequate self-care confidence (OR = 1.74; &lt;i&gt;P&lt;/i&gt; &lt; 0.001) were associated with greater involvement. Compared with no patient involvement, joint (β = -0.58; &lt;i&gt;P&lt;/i&gt; = 0.026) and patient-led (β = -0.59; &lt;i&gt;P&lt;/i&gt; = 0.014) decision making were associated with lower distress, while family/physician-led (β = 4.37; &lt;i&gt;P&lt;/i&gt; = 0.001), joint (β = 3.86; &lt;i&gt;P&lt;/i&gt; &lt; 0.001), patient-led (β = 3.46; &lt;i&gt;P&lt;/i&gt; &lt; 0.001), and patient-alone (β = 3.99; &lt;i&gt;P&lt;/i&gt; &lt; 0.001) decision making were associated with better spiritual well-being.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;A substantial proportion of patients was not involved in decision making. Patients should be encouraged to participate in decision making since it is associated with lower distress and better spiritual well-being.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Highlights: &lt;/strong&gt;The level of involvement in medical decision making did not change over time among patients with heart failure. A substantial proportion of patients were not involved in decision making throughout the 24-mo study period.Patients' involvement in decision making varied by age, ethnicity, education level, marital status, awareness of the terminal condition, and confidence in self-care.Compared with no patient involvement in decision making, joint and patient-led decision making were associated with lower distress, and any level of patient involvement in decision making","PeriodicalId":49839,"journal":{"name":"Medical Decision Making","volume":" ","pages":"863-874"},"PeriodicalIF":3.6,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41164523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Medical Decision Making
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1